Skip to main content

AstraZeneca

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology corporation specializing in the discovery, development, manufacturing, and commercialization of prescription medications across major therapeutic areas including oncology, cardiovascular, renal, metabolism, respiratory, immunology, and rare diseases. The company operates state-of-the-art research laboratories and global manufacturing facilities, delivering innovative medicines to healthcare systems worldwide. Its core business activities encompass biopharmaceutical research, clinical drug trials, regulatory compliance, and global commercial distribution. Revenue is derived primarily from direct commercial sales of branded prescription pharmaceuticals to wholesalers, pharmacies, and healthcare institutions. AstraZeneca holds a leading global market position in oncology and biopharmaceutical drug manufacturing. The company is headquartered in Cambridge, United Kingdom, and its shares trade on the London Stock Exchange, Nasdaq Stockholm, and the New York Stock Exchange.

256 of the funds FundTelligence covers report a position in AstraZeneca.

Legal name
AstraZeneca PLC
Sector
Health Care
Country
United Kingdom
Funds holding it
256
Exposure themes
Multiple, Treatment, Women's Health

Funds holding AstraZeneca

Showing the 8 largest of 256 funds holding it.

Loading...